Particulars |
|
|
|
Company Name
| Glenmark Pharmaceuticals Ltd
| Year End
| 202303
|
Full Year |
Equity (₹ Cr.) |
28.22 |
B.V. (₹) |
651.20 |
Sales(₹ Cr.) |
8,220.66 |
NP (₹ Cr.) |
1,578.33 |
NP Var (%) |
-4.00 |
Div% |
250.00 |
CPS(₹) |
62.50 |
EPS (₹) |
55.90 |
Traded Value(₹ Lakhs) |
238.95 |
52 Week High |
1,098.00 |
52 Week Low |
539.00 |
Price BSE |
1,054.00 |
Price NSE |
1,053.00 |
Market Capital (₹ Cr.) |
29,742.63 |
P/C Ratio |
16.90 |
P/E Ratio |
18.80 |
Price Vs.BV |
1.62 |
|
Latest Quarter |
Year End |
202312 |
Sales (₹ Cr.) |
1,304.16 |
NP(₹ Cr.) |
4.87 |
NP Var % |
-98.00 |
Trailing Twelve Months |
Year End |
202312 |
Sales |
7,753.95 |
OPM |
28.67 |
NP |
1,669.85 |
NP Var (%) |
-26.57 |
EPS |
37.29 |
PE |
28.26 |
|
|